Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon Wins Boehringer Contracts | Contract Pharma

What are you searching for?

Sign in
Breaking News

Patheon Wins Boehringer Contracts

Two diabetes projects valued at more than $18 million

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Boehringer Ingelheim has awarded Patheon with two projects valued at more than $18 million during a three-year period. The projects are both fixed-dose combination drugs in development for the treatment of type II diabetes.

Mark Kontny, Patheon’s president of Pharmaceutical Development Services and chief scientific officer said, “I am very gratified that Boehringer Ingelheim recognizes our expertise in formulating, scaling and successfully launching complex formulations such as these molecules. It is this kind of support and recognition that has enabled us to develop our market leading position in pharmaceutical development services.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters